TETRA BIO-PHARMA
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program. Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.
TETRA BIO-PHARMA
Industry:
Biopharma Biotechnology Cannabis Health Care Medical Pharmaceutical
Founded:
2007-05-17
Address:
Ottawa, Ontario, Canada
Country:
Canada
Website Url:
http://www.tetrabiopharma.com
Total Employee:
11+
Status:
Active
Contact:
1 (343) 780 2020
Email Addresses:
[email protected]
Total Funding:
47.47 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Font Awesome Global Site Tag Contact Form 7
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Truetiva
Truetiva is a biotech company that focuses on making pharmaceutical drug delivery technology for efficiently delivering cannabinoids.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-30 | Panag Pharma | Panag Pharma acquired by Tetra Bio-Pharma | 12 M USD |
| 2016-06-22 | Laboratoires Holizen | Laboratoires Holizen acquired by Tetra Bio-Pharma | N/A |
| 2015-03-11 | Export Hydro | Export Hydro acquired by Tetra Bio-Pharma | N/A |
Investors List
Alpha Blue Ocean
Alpha Blue Ocean investment in Post-IPO Debt - Tetra Bio-Pharma
Ministère de l'Économie et de l'Innovation
Ministère de l'Économie et de l'Innovation investment in Post-IPO Debt - Tetra Bio-Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-14 | Alpha Blue Ocean | Tetra Bio-Pharma investment in Debt Financing - Alpha Blue Ocean | 10 M CAD |
| 2020-10-27 | Mondias Natural Products | Tetra Bio-Pharma investment in Post-IPO Equity - Mondias Natural Products | N/A |
| 2015-02-12 | Herbaceous Inc. | Tetra Bio-Pharma investment in Funding Round - Herbaceous Inc. | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-30 | Tetra Bio-Pharma Appoints Chief Financial Officer |
Official Site Inspections
http://www.tetrabiopharma.com Semrush global rank: 10.02 M Semrush visits lastest month: 280
- Host name: 89.116.181.55
- IP address: 89.116.181.55
- Location: Eriskiai Republic of Lithuania
- Latitude: 55.5833
- Longitude: 24.2667
- Timezone: Europe/Vilnius
More informations about "Tetra Bio-Pharma"
Tetra Bio-Pharma - LinkedIn
Tetra Bio-Pharma (TSX: TBP) (OTC-Pink: TBPMF) (FRA: JAM1) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing …See details»
Tetra Bio-Pharma - Crunchbase Company Profile & Funding
Organization. Tetra Bio-Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Tetra Bio-Pharma is a …See details»
Tetra Bio Pharma Inc. | The Canadian Securities Exchange (CSE)
Jan 5, 2015 tetrabiopharma.com Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP) engaged in the development of Bio Pharmaceuticals and Natural Health Products …See details»
Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug
Nov 18, 2022 For more information visit: www.tetrabiopharma.com. ... Organization Profile. Tetra Bio-Pharma Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact UsSee details»
Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal
Feb 22, 2021 For more information visit: www.tetrabiopharma.com. Forward-looking statements. ... Organization Profile. Tetra Bio-Pharma Inc. Contact Cision. 866-245-2317 from 8 AM - 10 …See details»
Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed …
Dec 21, 2021 For more information visit: www.tetrabiopharma.com. SOURCE Tetra Bio-Pharma Inc. ... Organization Profile. Tetra Bio-Pharma Inc. Contact Cision. 866-245-2317 from 8 AM - …See details»
Tetra Bio-Pharma - Overview, News & Similar companies - ZoomInfo
Nov 29, 2022 www.tetrabiopharma.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Tetra Bio-Pharma Announces Listing to OTCPink Market. …See details»
Tetra Bio-Pharma Voluntary Bankruptcy - TheNewswire
Aug 1, 2023 Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) () (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development …See details»
Tetra Bio-Pharma Company Profile - Office Locations ... - Craft
Nov 17, 2023 Tetra Bio-Pharma has 5 employees across 2 locations. See insights on Tetra Bio-Pharma including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
TETRA BIO-PHARMA INC. (the “Corporation”)
6 CORPORATE SOCIAL RESPONSIBILITY, ETHICS AND INTEGRITY The Board will provide leadership to Tetra in support of its commitment to Corporate Social Responsibility, set the …See details»
Tetra Bio-Pharma OTCPK:TBPM.Q Stock Report - Simply Wall St
6 days ago www.tetrabiopharma.com: Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, …See details»
Tetra Bio-Pharma Cancels New Drug Submission to Health Canada …
May 11, 2023 MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid …See details»
Tetra Bio-Pharma Inc. (TBPMQ) - Yahoo Finance
Find the latest Tetra Bio-Pharma Inc. (TBPMQ) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Tetra Bio-Pharma Acquires Exclusive Global Technology Rights to a ...
Oct 21, 2020 Tetra will leverage its recent Dronabinol data pack acquisition to rapidly file its second New Drug Submission application to commercialize another THC-based prescription …See details»
Tetra Bio-Pharma Announces Up To $13.0 Million Marketed
Dec 1, 2021 For more information visit: www.tetrabiopharma.com. ... Organization Profile. Tetra Bio-Pharma Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a …See details»
Tetra Bio-Pharma Inc. Announces Changes to its Board of
May 18, 2021 For more information visit: www.tetrabiopharma.com. Forward-looking statements. ... Organization Profile. Tetra Bio-Pharma Inc. Contact Cision. 866-245-2317 from 8 AM - 10 …See details»
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1
Apr 23, 2021 OTTAWA, ON / ACCESSWIRE / April 23, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and …See details»
Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug …
Nov 18, 2022 Tetra Bio-Pharma (OTCQB: TBPMF) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed …See details»
Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with …
Mar 17, 2022 The Type C meeting with the FDA provides guidance to strengthen QIXLEEF™ nonclinical and toxicological data package for marketing approval. OTTAWA, ON, March 17, …See details»
Tetra Bio-Pharma Receives $4.5M from the Ministère de l
Feb 16, 2022 For more information visit: www.tetrabiopharma.com About ARDS-003 ARDS-003 is an immunomodulator drug aimed at preventing and treating the serious, life-threatening …See details»